Brief: Venus Remedies Gets Saudi Marketing Approval For Docetaxel
01/06/2023 05:59
June 1 (Reuters) - Venus Remedies Ltd VENR.NS :
* GETS SAUDI MARKETING APPROVAL FOR DOCETAXEL
Source text for Eikon: ID:nBSEbzrFgf
Further company coverage: VENR.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Venus Remedies
See all newsBrief: Venus Remedies Sept-Quarter Consol Net Profit 256.5 Million Rupees
Brief: Venus Remedies Secured Five Marketing Authorisations Across Kazakhstan, Peru, Kuwait And Argentina
India's Venus Remedies rises after quarterly profit more than doubles
Brief: Venus Remedies June-Quarter Consol Net Profit 229.7 Million Rupees
India raises price cap on cancer drugs to tackle shortage